Metabolite profiling of Alzheimer's disease cerebrospinal fluid.

Metabolite profiling of Alzheimer's disease cerebrospinal fluid.

Alzheimer's disease (AD) is a neurodegenerative disorder characterized by progressive loss of cognitive functions. Today the diagnosis of AD relies on clinical evaluations and is only late in the disease. Biomarkers for early detection of the underlying neuropathological changes are still lacki...

Full description

Bibliographic Details
Main Authors:	Christian Czech, Peter Berndt, Kristina Busch, Oliver Schmitz, Jan Wiemer, Veronique Most, Harald Hampel, Jürgen Kastler, Hans Senn
Format:	Article
Language:	English
Published:	Public Library of Science (PLoS) 2012-01-01
Series:	PLoS ONE
Online Access:	http://europepmc.org/articles/PMC3281064?pdf=render

Similar Items

Associations of cerebrospinal fluid amyloidogenic nanoplaques with cytokines in Alzheimer’s disease
by: Mari Aksnes, et al.
Published: (2021-06-01)

Association of oxidative stress and inflammatory metabolites with Alzheimer’s disease cerebrospinal fluid biomarkers in mild cognitive impairment
by: Ahmad, S, et al.
Published: (2024)

Analysis of the Cerebrospinal Fluid Proteome in Alzheimer's Disease.
by: Payam Emami Khoonsari, et al.
Published: (2016-01-01)

Alzheimer disease pathology and the cerebrospinal fluid proteome
by: Loïc Dayon, et al.
Published: (2018-07-01)

Metabolites and Biomarker Compounds of Neurodegenerative Diseases in Cerebrospinal Fluid
by: Keiji Wakamatsu, et al.
Published: (2022-04-01)

Comparative analysis of cerebrospinal fluid metabolites in Alzheimer’s disease and idiopathic normal pressure hydrocephalus in a Japanese cohort
by: Yuki Nagata, et al.
Published: (2018-01-01)

Cerebrospinal Fluid Biomarkers of Alzheimer's Disease Show Different but Partially Overlapping Profile Compared to Vascular Dementia
by: Franc Llorens, et al.
Published: (2017-09-01)

Cerebrospinal fluid biomarkers for the differential diagnosis of Alzheimer’s disease
by: Carolina A. Magalhães, et al.
Published: (2015-12-01)

Cerebrospinal fluid biomarkers in early diagnosis of Alzheimer's disease
by: Jun WANG, et al.
Published: (2014-04-01)

Elevated cerebrospinal fluid pressure in patients with Alzheimer's disease
by: Fellmann Jere, et al.
Published: (2006-05-01)

Cerebrospinal fluid biomarkers for Alzheimer's disease in Down syndrome
by: Alain D. Dekker, et al.
Published: (2017-01-01)

A cerebrospinal fluid biosignature for the diagnosis of Alzheimer’s disease
by: Tatiana Barichello, et al.
Published: (2019-12-01)

Maternal Cerebrospinal Fluid Glutamate in Response to Variable Foraging Demand: Relationship to Cerebrospinal Fluid Serotonin Metabolites in Grown Offspring
by: Jeremy D. Coplan, et al.
Published: (2018-07-01)

Proteome profiling in cerebrospinal fluid reveals novel biomarkers of Alzheimer's disease
by: Jakob M Bader, et al.
Published: (2020-06-01)

Immunoglobulin and other proteins in the cerebrospinal fluid of patients with Alzheimer's disease.
by: Chapel, H, et al.
Published: (1984)

Diagnostic and progression biomarkers in cerebrospinal fluid of Alzheimer’s disease patients
by: Miyo K. Chatanaka, et al.
Published: (2024-02-01)

Plasma and cerebrospinal fluid cholesterol esterification is hampered in Alzheimer’s disease
by: Marta Turri, et al.
Published: (2023-05-01)

Isoprostanoids Levels in Cerebrospinal Fluid Do Not Reflect Alzheimer’s Disease
by: Carmen Peña-Bautista, et al.
Published: (2020-05-01)

POTENTIAL ALTERATION IN THE NICASTRIN LEVELS IN ALZHEIMER’S DISEASE CEREBROSPINAL FLUID
by: Luis Felipe Hernández-Villamizar, et al.
Published: (2023-10-01)

Protein fibril length in cerebrospinal fluid is increased in Alzheimer’s disease
by: Peter Niraj Nirmalraj, et al.
Published: (2023-03-01)

Cerebrospinal fluid microRNAs as potential biomarkers in Alzheimer’s disease
by: Ahmed Noor Eddin, et al.
Published: (2023-07-01)

Cerebrospinal fluid biomarker panel for synaptic dysfunction in Alzheimer's disease
by: Johanna Nilsson, et al.
Published: (2021-01-01)

Apolipoprotein E imbalance in the cerebrospinal fluid of Alzheimer’s disease patients
by: Matthew Paul Lennol, et al.
Published: (2022-11-01)

Latest advances in cerebrospinal fluid and blood biomarkers of Alzheimer’s disease
by: Marta Milà-Alomà, et al.
Published: (2019-12-01)

Cerebrospinal fluid antibodies to oxidized LDL are increased in Alzheimer's disease
by: Jari Kankaanpää, et al.
Published: (2009-03-01)

Cerebrospinal fluid and blood biomarkers in the diagnostic assays of Alzheimer’s disease
by: Liding Zhang, et al.
Published: (2022-01-01)

Effects of cerebrovascular disease on amyloid precursor protein metabolites in cerebrospinal fluid
by: Rosengren Lars, et al.
Published: (2010-07-01)

Cerebrospinal Fluid Mitochondrial DNA in Rapid and Slow Progressive Forms of Alzheimer’s Disease
by: Petar Podlesniy, et al.
Published: (2020-08-01)

Distinct cerebrospinal fluid amyloid β peptide signatures in sporadic and <it>PSEN1 </it>A431E-associated familial Alzheimer's disease
by: Galasko Douglas, et al.
Published: (2010-01-01)

Peptide fingerprinting of Alzheimer's disease in cerebrospinal fluid: identification and prospective evaluation of new synaptic biomarkers.
by: Holger Jahn, et al.
Published: (2011-01-01)

Cholinesterase activities in cerebrospinal fluid of patients with senile dementia of Alzheimer type.
by: Appleyard, M, et al.
Published: (1987)

Association of lysophosphatidic acids with cerebrospinal fluid biomarkers and progression to Alzheimer's disease
by: Ahmad, S, et al.
Published: (2020)

Cerebrospinal fluid biomarker profiling of diverse pathophysiological domains in Alzheimer's disease
by: Bianca A. Trombetta, et al.
Published: (2024-01-01)

Cerebrospinal Fluid Biomarkers of Alzheimer’s Disease: Current Evidence and Future Perspectives
by: Donovan A. McGrowder, et al.
Published: (2021-02-01)

Cerebrospinal fluid lipidomic fingerprint of obstructive sleep apnoea in Alzheimer’s disease
by: Farida Dakterzada, et al.
Published: (2023-08-01)

Cerebrospinal Fluid Biomarkers for Alzheimer’s Disease in the Era of Disease-Modifying Treatments
by: George P. Paraskevas, et al.
Published: (2021-09-01)

Plasma and cerebrospinal fluid nonenzymatic protein damage is sustained in Alzheimer's disease
by: Farida Dakterzada, et al.
Published: (2023-08-01)

Cerebrospinal fluid catecholamines in Alzheimer’s disease patients with and without biological disease
by: Kristi Henjum, et al.
Published: (2022-04-01)

Cerebrospinal fluid amyloid beta and tau protein: Biomarkers for Alzheimer's disease
by: Mandić Gorana, et al.
Published: (2008-01-01)

Case Report: Alzheimer's Dementia Associated With Cerebrospinal Fluid Neurochondrin Autoantibodies
by: Niels Hansen, et al.
Published: (2022-06-01)